We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Akili Inc | NASDAQ:AKLI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0088 | -2.15% | 0.40 | 0.4068 | 0.42 | 109 | 09:55:35 |
Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will participate in the Cowen 43rd Annual Health Care Conference in Boston next month.
On March 8, Akili sessions are scheduled for the following times:
Company leaders will also meet with investors throughout the day on March 8.
About Akili
Akili is pioneering the development of cognitive treatments through game-changing technologies. Akili’s approach of leveraging technologies designed to directly target the brain establishes a new category of medicine – medicine that is validated through clinical trials like a drug or medical device but experienced like entertainment. Akili’s platform is powered by proprietary therapeutic engines designed to target cognitive impairment at its source in the brain, informed by decades of research and validated through rigorous clinical programs. Driven by Akili’s belief that effective medicine can also be fun and engaging, Akili’s products are delivered through captivating action video game experiences. For more information, please visit www.akiliinteractive.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230202005499/en/
Investor Contact: Santosh Shanbhag Chief Financial Officer sshanbhag@akiliinteractive.com
Media Contact: Julie DiCarlo SVP, Communications jdicarlo@akiliinteractive.com
1 Year Akili Chart |
1 Month Akili Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions